Beta test rollout. This site is in community QA — please send feature requests, bug reports and data corrections on the Feedback page or on GitHub.

Home
    Disclaimer
    FXE molecular structure

    FXE Stats & Data

    3f-o-pce fluorexetamine
    PubChem
    MW235.30
    FormulaC14H18FNO
    LogP2.4
    IUPAC2-(ethylamino)-2-(3-fluorophenyl)cyclohexan-1-one
    InChIKeyFCETYWCLCUZFJI-UHFFFAOYSA-N
    Chemical Class Arylcyclohexylamine
    Psychoactive Class Dissociative
    Half-Life Unknown in humans; user reports suggest short–moderate elimination (roughly a few hours), but no formal PK data located.

    Toxicity

    PsychonautWiki

    ===Dangerous interactions=== Warning: Many psychoactive substances that are reasonably safe to use on their own can suddenly become dangerous and even life-threatening when combined with certain other substances. The following list provides some known dangerous interactions (although it is not guaranteed to include all of them). Always conduct independent research (e.g. Google, DuckDuckGo, PubMed) to ensure that a combination of two or more substances is safe to consume. Some of the listed interactions have been sourced from TripSit.

    Effect Profile

    Curated + 3 Reports
    Dissociative 6.0

    Strong dissociative depth and motor impairment with mild mania, low insight

    Dissociative Depth×3
    10
    Mania / Compulsion×1
    4
    Insight / Novel Thought×2
    3
    Motor / Sensory Impairment×1
    10

    Tolerance & Pharmacokinetics

    drugs.wiki
    Half-Life
    Unknown in humans; user reports suggest short–moderate elimination (roughly a few hours), but no formal PK data located.
    Addiction Potential
    Moderate; dissociatives can foster compulsive redosing and psychological dependence, particularly with frequent use.

    Tolerance Decay

    Full tolerance 1d Half tolerance 14d Baseline ~28d

    Estimates are based on dissociative class patterns and user reports rather than controlled studies. Cross‑tolerance within arylcyclohexylamines is common; allowing 2–4+ weeks between sessions reduces tolerance significantly.

    Cross-Tolerances

    Ketamine
    70% ●○○
    MXE (Methoxetamine)
    70% ●○○
    O‑PCE
    70% ●○○
    2‑FDCK
    60% ●○○
    DXM
    50% ●○○

    Experience Report Analysis

    Erowid
    7 Reports
    3 Single-substance
    2022–2024 Date Range
    7 With Age Data
    1 Effects Detected

    Demographics

    Gender Distribution

    Too few reports for a chart: gender is known from 7 reports, and a split is drawn only from 20 reports or more. Counts are shown instead. Why 20?

    • Not Specified 2 of 7
    • Male 4 of 7
    • Female 1 of 7

    Age Distribution

    Reports Over Time

    Effect Analysis

    Erowid

    Effects aggregated from 3 experience reports (3 single-substance Erowid)

    3 Reports
    1 Effects Detected
    0 Positive
    0 Adverse
    1 Neutral

    Effect Sentiment Distribution

    Confidence Distribution

    Each bar is the share of reports mentioning the effect; its whisker, and the band on the rows below, is the 95% interval: where the share could plausibly be with other reports of the same kind.

    Too few reports for bars: these effects come from 3 single-substance Erowid reports, and a bar is drawn only from 20 reports or more. With fewer, a percentage cannot tell a common effect from a rare one. Counts are shown instead. Why 20?

    Positive Effects 0

    Adverse Effects 0

    Real-World Dose Distribution

    62K Doses

    From 8 individual dose entries. Values above Q3 + 3×IQR are left out as outliers.

    Insufflated (n=8)

    Median: 55.0mg 25th: 41.25mg 75th: 126.25mg 90th: 184.0mg

    Form / Preparation

    Most common forms and preparations, as a share of the 7 reports that give one

    Too few reports for bars: these forms come from 7 reports, and a bar is drawn only from 20 reports or more. With fewer, a percentage cannot tell a common effect from a rare one. Counts are shown instead. Why 20?

    • Powder / Crystals 5 of 7
    • Ground / Crushed 2 of 7

    Harm Reduction

    drugs.wiki

    - Identity and purity vary in the unregulated market; drug checking is strongly recommended. Toronto’s Drug Checking Service and similar services often detect unexpected actives in samples; start with an allergy dose and avoid unknown vendors.

    - Combining dissociatives with CNS depressants (alcohol, benzos, opioids, GHB/GBL) greatly increases risks of blackout, airway compromise, and respiratory depression; place anyone unconscious in the recovery position and call emergency services.

    - Frequent/heavy arylcyclohexylamine use is linked to ulcerative cystitis and other urinary tract injury (data strongest for ketamine). Given structural similarity and user reports, apply the same precautions to FXE: minimize frequency, stay well‑hydrated during/after use, and stop if urinary pain/urgency/hematuria emerge.

    - Dissociatives can impair coordination and judgment; sit or lie down during peaks, avoid heights/water, and strictly avoid driving/operating machinery until fully baseline the next day. Ketamine references note sedation and slowed breathing at high doses—caution is extrapolated to FXE.

    - High or prolonged dissociative intoxication can precipitate rhabdomyolysis; seek urgent care if you develop severe muscle pain, dark (tea‑colored) urine, or decreased urination after a session.

    - Insufflation irritates nasal mucosa and encourages redosing. To reduce harm: use separate, clean straws; rotate nostrils; space sessions; and gently rinse with sterile saline 15–30 minutes post‑use. General community HR guidance supports nasal care.

    - Intramuscular use has appeared in community reports but carries additional risks (infection, dosing errors). If someone chooses IM, sterile technique, micron filtration, and accurate volumetric dosing are essential; this is not recommended for novices.

    - Tolerance to dissociatives builds rapidly; even weekly use can markedly blunt effects, encouraging escalation. Long breaks (2–4+ weeks) help reset tolerance.

    - FXE is often described as ketamine‑like with unique nuances; individuals vary widely in sensitivity. Dose conservatively, especially if on serotonergic meds (limited human interaction data for FXE; MXE showed SRI activity).

    - Because FXE is sold as a research chemical, mislabeling/adulteration occur. Visually atypical powders and unexpected effects warrant immediate cessation and testing; some user reports describe anomalous batches.

    ← Back to FXE